REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION

As filed

Subsection

03

Classification

1200

Street

1333 NEW HAMPSHIRE AVE NW STE 420

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2025

• Advancing Regulatory Science- Provide data assets, evaluation tools, and career development opportunities to help FDA assess the risks and benefits of regulated products. Examples include the the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, Fellowship in Regulatory Science & Innovation, and the ASH Real-World Evidence Consortium.

  Expenses $4,762,759 · Revenue $4,124,414

• Supporting Development and Dissemination of Reliable Information- Improve public understanding of the risks and benefits of FDA-regulated products. Identify priority areas for consumer, patient, and provider education in areas of emerging science. Examples include Expanded Access Navigator, Nutrition Communications Network, Improving Human Health Risk Communication, and Animal Health and Veterinary Industry Analysis.

  Expenses $2,294,319 · Revenue $15,000

• Facilitating Engagement and Information Exchange - Facilitate multi-stakeholder collaboration to accelerate evidence generation and dissemination. Enable expert analysis, candid discussion, and actionable recommendations relevant to the FDA Mission. Examples include Healthy Rule Roundtables, Food Traceability Roundtables, Primary Mitochondrial Diseases Workshop, FDA Patient Listening Sessions, and Biosimilars Development Regulatory Science Accelerator.

  Expenses $1,491,110 · Revenue $129,938

As filed on the 2025 return.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

• 2025

  Revenue

  $8,703,093

  Expenses

  $8,934,898

  Contributions

  $4,433,334

  Grants paid

  $0

• 2024

  Revenue

  $8,241,574

  Expenses

  $7,880,139

  Contributions

  $4,788,188

  Grants paid

  $0

• 2023

  Revenue

  $8,216,727

  Expenses

  $7,790,276

  Contributions

  $4,698,615

  Grants paid

  $10,000

• 2022

  Revenue

  $8,752,229

  Expenses

  $8,633,422

  Contributions

  $5,204,924

  Grants paid

  $0

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

• 2021 · 990

  Revenue

  $5,435,911

  Expenses

  $5,303,683

  Assets (EOY)

  $4,910,430

• 2020 · 990

  Revenue

  $4,858,127

  Expenses

  $4,442,490

  Assets (EOY)

  $5,042,218

• 2019 · 990

  Revenue

  $2,778,525

  Expenses

  $2,521,247

  Assets (EOY)

  $4,065,358

• 2018 · 990

  Revenue

  $2,433,027

  Expenses

  $1,847,661

  Assets (EOY)

  $3,164,298

• 2017 · 990

  Revenue

  $2,880,198

  Expenses

  $1,790,422

  Assets (EOY)

  $2,656,084

• 2016 · 990

  Revenue

  $3,669,607

  Expenses

  $2,605,466

  Assets (EOY)

  $1,807,309

• 2015 · 990

  Revenue

  $3,849,081

  Expenses

  $4,516,197

  Assets (EOY)

  $1,384,427

• 2014 · 990

  Revenue

  $4,226,053

  Expenses

  $3,953,281

  Assets (EOY)

  $2,248,205

• 2013 · 990

  Revenue

  $4,166,841

  Expenses

  $4,065,970

  Assets (EOY)

  $1,478,340

• 2012 · 990

  Revenue

  — not reported

  Expenses

  $851,761

  Assets (EOY)

  $1,151,882

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

• Friends of Cancer Research

  $10,000

  2023 · 2023 Annual Cancer Leadership Awards sponsorship

Where these grants went next →

Grants received

• PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

  $50,000

  2024 · GENERAL CONTRIBUTION

• PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

  $30,000

  2023 · General Contribution

• UNITED STATES PHARMACOPEIAL CONVENTION INC

  $15,000

  2024 · ANNUAL INNOVATIONS IN REGULATORY SCIENCE AWARDS - SPONSORSHIP

• UNITED STATES PHARMACOPEIAL CONVENTION INC

  $15,000

  2023 · 2023 INNOVATIONS IN REGULATORY SCIENCE AWARDS CELEBRATION SPONSORSHIP

• UNITED STATES PHARMACOPEIAL CONVENTION INC

  $8,000

  2022 · NATIONAL HEALTH COUNCIL 2023 DUES

Other IRS files